Across Africa, the pharmaceutical and MedTech sectors are entering a defining era. Markets are expanding, regulatory systems are maturing, and demand for high-quality, compliant products has never been greater. Yet, for many manufacturers and distributors, one challenge remains constant: navigating…
The International Council for Harmonisation (ICH) guidelines represent the global benchmark for the design, conduct, monitoring, and reporting of clinical trials. For South Africa, where clinical research plays a critical role in public health, scientific advancement, and economic development, adherence…
South Africa has become one of the most active clinical trial hubs in Africa, with studies ranging from HIV prevention and tuberculosis vaccines to oncology and rare diseases. International sponsors, including the U.S. National Institutes of Health (NIH), the Bill…
South Africa has emerged as one of the most important clinical research destinations in Africa. With a high burden of diseases such as HIV, tuberculosis, cancer, and cardiovascular conditions, the country offers access to diverse patient populations that are essential…
Some companies focus on ticking boxes. GH Strategies focuses on building legacies. From its earliest beginnings, GH Strategies set out to change the way pharmaceutical, medical device, and biotechnology companies in South Africa experience regulatory and quality consulting. What began…
South Africa is one of Africa’s largest and most established hubs for clinical research, hosting hundreds of active trials across HIV, tuberculosis, oncology, vaccines, and emerging therapeutic areas. These studies are frequently funded by international sponsors such as the National…
A Regulatory Interpretation of Scope, Classification, and Compliance Obligations Table of Contents 1. Introduction: Why Regulatory Distinction Matters in South Africa 2. South Africa’s Regulatory Architecture for Health Products 3. Legal Definitions Under South African Law 3.1 What Constitutes a…
In today’s life sciences and pharma sector, quality is not optional. It is the foundation upon which trust, safety, and market access are built. Nowhere is this more apparent than in the pharmaceutical and medical device industries, where regulatory scrutiny…
Table of Contents Introduction: Pharmacovigilance as a Pillar of Public Health and Governance Defining Pharmacovigilance in the African Regulatory Context Why Pharmacovigilance Matters Across the Pharmaceutical Lifecycle Objectives and Scope of Pharmacovigilance Systems Regulatory and Legislative Foundations for Pharmacovigilance in…